D&O Disclosure Notice - Hugo Fisher
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Black Pearl Group Limited
Date this disclosure made:
18/07/2025
Date of last disclosure:
18/07/2024
Director or senior manager giving disclosure
Full name(s):
Hugo Robert Heathcote Fisher
Name of listed issuer:
Black Pearl Group Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):
Registered Holder
For that relevant interest-
Number held in class before acquisition or disposal:
71,429
Number held in class after acquisition or disposal:
142,857
Current registered holder(s):
N/A
Registered holder(s) once transfers are registered:
Hugo Fisher
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:18/07/2025
Nature of transaction:
Issue of ordinary shares upon
conversion of Restricted Shares
allocated to Hugo Fisher under
director appointment letter.
Name of any other party or parties to the transaction (if known):N/A
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Services provided in accordance with
the terms of the director appointment
letter.
Number of financial products to which the transaction related: 71,428 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Docusign Envelope ID: 40EF96D3-D3A9-4E11-BA83-CB1662445711
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:N/A
Nature of relevant interest:N/A
For that relevant interest,-
Number held in class:N/A
Current registered holder(s):N/A
For a derivative relevant interest,-
Type of derivative:N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
Docusign Envelope ID: 40EF96D3-D3A9-4E11-BA83-CB1662445711
18/7/2025
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: Ongoing Disclosure Notices - Options, PSRs, Ordinary Shares2025-09-17
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Date this disclosure made: 18 Septe…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Ongoing Disclosure Notice – Ordinary Shares2025-06-13
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Date this disclosure made: 13 June…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Ongoing Disclosure Notice - Ordinary Shares2025-10-01
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Date this disclosure made: 2 Octobe…”